Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: dopamine agonist (Click to remove) Degenerative Diseases of the Nervous System, Parkinson Disease Adams & Victors Principles of Neurology, Chp 39, pg 1082, Ropper, A.H.,et al, 2014 Parkinsons Disease Lancet 373:2055-2066, Lees,A.J.,et al, 2009 Clinical Features of Dopamine Agonist Withdrawal Syndrome in a Movement Disorders Clinic JNNP 84:130-135, Pondal, M.,et al, 2013 Treatment Options in the Modern Management of Parkinson Disease Arch Neurol 64:1083-1088, Schapira,A.H.V., 2007 A Five-Year Study of the Incidence of Dyskinesia in Patients With Early Parkinson's Disease who were Treated with Ropinirole or Levodopa NEJM 342:1484-1491, Rascol,O.,et al, 2000 Acute Orhtostatic Hypotension When Starting Dopamine Agonists in Parkinson's Disease Arch Neurol 57:1461-1463, Kujawa,K.,et al, 2000 Drug Treatment of Parkinson's Disease BMJ 310:575-579, Quinn,N., 1995 Parkinson's Disease JNNP 57:672-681, Marsden,C.D., 1994 The Efficacy of (+) -4-Propyl-9-Hydroxynaphthoxazine as Adjunctive Therapy in Parkinson's Disease JNNP 52:732-735, Weiner,W.J.,et al, 1989 Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986 Progressive Supranuclear Palsy:Clinical Features & Response to Treatment in 16 Patients Ann Neurol 13:273-278, Jackson,J.A.,et al, 1983 Drug Therapy, Bromocriptine NEJM 301:873-878, Parkes,D., 1979 Showing articles 0 to 12 of 12